Pharmacology

Action Mechanism of Action Reference
INHIBITOR Tumor necrosis factor ligand superfamily member 13B inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Purpura, Thrombocytopenic, Idiopathic 3 D016553 ClinicalTrials
Vasculitis 3 D014657 ClinicalTrials
Myositis 2 D009220 ClinicalTrials
Emphysema 2 D004646 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 2 D015451 ClinicalTrials
Nephrotic Syndrome 2 D009404 ClinicalTrials
Arthritis, Rheumatoid 2 D001172 ClinicalTrials
Scleroderma, Systemic 2 D012595 ClinicalTrials
Glomerulonephritis, Membranous 2 D015433 ClinicalTrials
Sjogren's Syndrome 2 D012859 ClinicalTrials
Multiple Sclerosis 2 D009103 ClinicalTrials
Kidney Diseases 2 D007674 ClinicalTrials
Polyendocrinopathies, Autoimmune 2 D016884 ClinicalTrials
Neuromyelitis Optica 1 D009471 ClinicalTrials
Lymphopenia 1 D008231 ClinicalTrials
Graft vs Host Disease 1 D006086 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL1789843
FDA SRS 73B0K5S26A